{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:06:13Z","timestamp":1791295573849,"version":"4.1.0"},"publisher-location":"Berlin, Heidelberg","reference-count":22,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783642355172","type":"print"},{"value":"9783642355189","type":"electronic"}],"license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012]]},"DOI":"10.1007\/8904_2012_180","type":"book-chapter","created":{"date-parts":[[2012,10,17]],"date-time":"2012-10-17T16:18:26Z","timestamp":1350490706000},"page":"67-71","source":"Crossref","is-referenced-by-count":11,"title":["Ceftriaxone for Alexander\u2019s Disease: A Four-Year Follow-Up"],"prefix":"10.1007","author":[{"given":"GianPietro","family":"Sechi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Ceccherini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Bachetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni A.","family":"Deiana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elia","family":"Sechi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Balbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,10,13]]},"reference":[{"key":"180_CR01801","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1016\/j.yexcr.2010.05.005","volume":"316","author":"T Bachetti","year":"2010","unstructured":"Bachetti T, Di Zanni E, Balbi P et al (2010) In vitro treatments with ceftriaxone promote elimination of mutant glial fibrillary acidic protein and transcription down-regulation. Exp Cell Res 316:2152\u20132165","journal-title":"Exp Cell Res"},{"key":"180_CR01802","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1007\/s00415-010-5706-1","volume":"257","author":"P Balbi","year":"2010","unstructured":"Balbi P, Salvini S, Fundar\u00f2 C et al (2010) The clinical spectrum of late-onset Alexander disease: a systematic literature review. J Neurol 257:1955\u20131962","journal-title":"J Neurol"},{"key":"180_CR01803","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/83679","volume":"27","author":"M Brenner","year":"2001","unstructured":"Brenner M, Johnson AB, Boesflug-Tanguy O, Rodriguez D, Goldman JE, Messing A (2001) Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease. Nat Genet 27:117\u2013120","journal-title":"Nat Genet"},{"key":"180_CR01804","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.1093\/hmg\/ddq227","volume":"19","author":"W Cho","year":"2010","unstructured":"Cho W, Brenner M, Peters N, Messing A (2010) Drug screening to identify suppressors of GFAP expression. Hum Mol Genet 19:3169\u20133178","journal-title":"Hum Mol Genet"},{"key":"180_CR01805","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1086\/504411","volume":"79","author":"M Perng Der","year":"2006","unstructured":"Der Perng M, Su M, Wen SF et al (2006) The Alexander disease-causing glial fibrillary acidic protein mutant, R416W, accumulates into Rosenthal fibers by a pathway that involves filament aggregation and tha association of \u03b1B-crystallin and HSP27. Am J Hum Genet 79:197\u2013213","journal-title":"Am J Hum Genet"},{"key":"180_CR01806","doi-asserted-by":"publisher","first-page":"10507","DOI":"10.1523\/JNEUROSCI.1494-12.2012","volume":"32","author":"CM Lapash Daniels","year":"2012","unstructured":"Lapash Daniels CM, Austin EV, Rockney DE et al (2012) Beneficial effects of Nrf2 overexpression in a mouse model of Alexander disease. J Neurosci 32:10507\u201310515","journal-title":"J Neurosci"},{"key":"180_CR01807","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/j.1471-4159.2009.06347.x","volume":"111","author":"J Lewerenz","year":"2009","unstructured":"Lewerenz J, Albrecht P, Tran Tien ML et al (2009) Induction of Nrf2 and xCT are involved in the action of the neuroprotective antibiotic ceftriaxone in vitro. J Neurochem 111:332\u2013343","journal-title":"J Neurochem"},{"issue":"57","key":"180_CR01808","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/ana.20406","volume":"2005","author":"R Li","year":"2005","unstructured":"Li R, Salomons G, Johnson AB, Naidu S et al (2005) Glial fibrillary acidic protein mutations in infantile, juvenile, and adult forms of Alexander disease. Ann Neurol 2005(57):310\u2013326","journal-title":"Ann Neurol"},{"key":"180_CR01809","first-page":"391","volume":"152","author":"A Messing","year":"1998","unstructured":"Messing A, Head MW, Galles K, Galbreath EJ, Goldman JE, Brenner M (1998) Fatal encephalopathy with astrocyte inclusions in GFAP transgenic mice. Am J Pathol 152:391\u2013398","journal-title":"Am J Pathol"},{"key":"180_CR018010","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s00018-003-3143-3","volume":"61","author":"C Mignot","year":"2004","unstructured":"Mignot C, Boespflug-Tanguy O, Gelot A, Dautigny A, Pham-Dinh D, Rodriguez D (2004) Alexander disease: putative mechanisms of an astrocytic encephalopathy. CMLS, Cell Mol Life Sci 61:369\u2013385","journal-title":"CMLS, Cell Mol Life Sci"},{"key":"180_CR018011","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1016\/j.yexcr.2007.04.035","volume":"313","author":"C Mignot","year":"2007","unstructured":"Mignot C, Delarasse C, Escaich S et al (2007) Dynamics of mutated GFAP aggregates revealed by real-time imaging of an astrocyte model of Alexander disease. Exp Cell Res 313:2766\u20132779","journal-title":"Exp Cell Res"},{"key":"180_CR018012","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1128\/AAC.37.7.1518","volume":"37","author":"R Nau","year":"1993","unstructured":"Nau R, Prange HW, Muth P et al (1993) Passage of cefotaxime and ceftriaxone into cerebrospinal fluid of patients with uninflamed meninges. Antimicrob Agents Chemother 37:1518\u20131524","journal-title":"Antimicrob Agents Chemother"},{"key":"180_CR018013","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nature03180","volume":"433","author":"JD Rothstein","year":"2005","unstructured":"Rothstein JD, Patel S, Regan MR et al (2005) \u03b2-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 433:73\u201377","journal-title":"Nature"},{"key":"180_CR018014","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.braindev.2009.03.006","volume":"31","author":"Y Sawaishi","year":"2009","unstructured":"Sawaishi Y (2009) Review of Alexander disease: beyond the classical concept of leukodystrophy. Brain Dev 31:493\u2013498","journal-title":"Brain Dev"},{"key":"180_CR018015","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1212\/WNL.45.12.2266","volume":"45","author":"JD Schwankhaus","year":"1995","unstructured":"Schwankhaus JD, Parisi JE, Gulledge WR, Chin L, Currier RD (1995) Hereditary adult-onset Alexander\u2019s disease with palatal myoclonus, spastic paraparesis, and cerebellar ataxia. Neurology 45:2266\u20132271","journal-title":"Neurology"},{"key":"180_CR018016","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.pnpbp.2009.11.021","volume":"34","author":"GP Sechi","year":"2010","unstructured":"Sechi GP, Matta M, Deiana GA et al (2010a) Ceftriaxone has a therapeutic role in Alexander disease. Prog Neuropsychopharmacol Biol Psychiatry 34:416\u2013417","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"180_CR018017","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1097\/NEN.0b013e3181fe9e86","volume":"69","author":"GP Sechi","year":"2010","unstructured":"Sechi GP, Balbi P, Bachetti T, Ceccherini I (2010b) Correspondence regarding: Alexander disease mutant glial fibrillary acidic protein compromises glutamate transport in astrocytes. J Neuropathol Exp Neurol 69:1271\u20131272","journal-title":"J Neuropathol Exp Neurol"},{"key":"180_CR018018","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.jhep.2011.03.033","volume":"55","author":"GP Sechi","year":"2011","unstructured":"Sechi GP, Balbi P, Bachetti T, Ceccherini I (2011) Safe drugs to fight mutant protein overload and alpha-1-antitrypsin deficiency. J Hepatol 55:949\u2013950","journal-title":"J Hepatol"},{"key":"180_CR018019","doi-asserted-by":"publisher","first-page":"10527","DOI":"10.1074\/jbc.M109.067975","volume":"285","author":"G Tang","year":"2010","unstructured":"Tang G, Perng MD, Wilk S, Quinlan R, Goldman JE (2010) Oligomers of mutant glial fibrillary acidic protein (GFAP) inhibit the proteasome system in Alexander disease astrocytes, and the small heat shock protein \u03b1B-crystallin reverse the inhibition. J Biol Chem 285:10527\u201310537","journal-title":"J Biol Chem"},{"key":"180_CR018020","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1097\/NEN.0b013e3181d3cb52","volume":"69","author":"R Tian","year":"2010","unstructured":"Tian R, Wu X, Hagemann TL, Sosunov AA, Messing A, McKham GM, Goldman JE (2010) Alexander disease mutant glial fibrillary acidic protein compromises glutamate transport in astrocytes. J Neuropathol Exp Neurol 69:335\u2013345","journal-title":"J Neuropathol Exp Neurol"},{"key":"180_CR018021","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1161\/01.STR.19.5.604","volume":"19","author":"JC Swieten van","year":"1988","unstructured":"van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J (1988) Interobserver agreement for the assessment of handicap in stroke patients. Stroke 19:604\u2013607","journal-title":"Stroke"},{"key":"180_CR018022","doi-asserted-by":"publisher","unstructured":"Yamada J, Jinno S (2011) Alterations in neuronal survival and glial reactions after axotomy by ceftriaxone and minocycline in the mouse hypoglossal nucleus. Neurosci Lett. doi:\n                  10.1016\/j.neulet.2011\n                  \n                . 09.051","DOI":"10.1016\/j.neulet.2011"}],"container-title":["JIMD Reports","JIMD Reports \u2013 Case and Research Reports, 2012\/6"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/8904_2012_180","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T10:58:03Z","timestamp":1557485883000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/8904_2012_180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"ISBN":["9783642355172","9783642355189"],"references-count":22,"URL":"https:\/\/doi.org\/10.1007\/8904_2012_180","relation":{},"ISSN":["2192-8304","2192-8312"],"issn-type":[{"value":"2192-8304","type":"print"},{"value":"2192-8312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]}}}